/Labcorp%20Holdings%20Inc_%20logo%20magnified-by%20ll_studio%20via%20Shutterstock.jpg)
Burlington, North Carolina-based Labcorp Holdings Inc. (LH) is a provider of laboratory services. It offers various tests, such as blood chemistry analyses, urinalyses, thyroid, PAP, substance abuse, and many more. With a market cap of $20.9 billion, Labcorp Holdings operates through Diagnostics Laboratories and Biopharma Laboratory Services segments.
While the healthcare major has lagged behind the broader market over the past year, it has notably outperformed in 2025. LH stock has gained 14.7% over the past 52 weeks and soared 9.6% on a YTD basis, compared to the S&P 500 Index’s ($SPX) 17.6% returns over the past year and 1.7% gains in 2025.